The FDA had issued notices over ads for Vimal Elaichi, alleging that the campaign amounted to surrogate promotion of Vimal Pan Masala, which is banned in Maharashtra
e4m Staff 39 minutes ago
Samsung India public policy chief Rajiv Aggarwal steps down: Reports 14 minutes ago
Vimal Elaichi case: Delhi HC rejects plea, putting celeb endorsements under lens 39 minutes ago
BharatPe ropes in Yugal Tiwari as Chief Product and Marketing Officer 1 hour ago
TRAI drops weekly TV ad reporting requirement after 12-minute ceiling removed 2 hours ago
When 3,000 followers cost more than 3 million: A creator outreach lesson 3 hours ago
SEE MORE
ABC seeks govt nod to audit digital news circulation 4 hours ago
From direct to diverse: Why India’s D2C playbook is moving beyond the websites 4 hours ago
When everyone has the same AI tools, where does creative advantage come from? 4 hours ago
The pitch that never happened 3 hours ago
What does an ad look like inside AI? ChatGPT and Google are starting to answer 3 hours ago
Cognizant appoints Bindya Raj as Vice President, Global GTM Head 3 days ago
BCCL restructuring may cut 5-10% of workforce across departments & publications 6 days ago
Anushree Bose joins GMR Airports as General Manager - Marketing 5 days ago
After Dentsu, IT raids Bioscope and Crayons over alleged tax violations 1 week ago
How Samsung turned Apple’s first foldable into a global competitive-marketing moment 3 days ago